한글목차

북미의 블리스터 포장 시장은 예측 기간 동안 CAGR 7.5%를 나타낼 것으로 예상됩니다.

주요 하이라이트

• 북미에서 블리스터 포장은 완만한 성장세를 보이고 있습니다. 블리스터 포장 솔루션이 제공하는 높은 안전성으로 인해 수요가 증가하고 있습니다. 엄격한 규제와 제조업체 및 소비자 수요로 인해 블리스터 포장에 대한 수요가 증가하고 있습니다. 시판 의약품의 성장도 시장을 활성화시키고 있습니다.
• 질병 증가와 위조 의약품에 대한 정부의 엄격한 규제로 인해 제약회사에 대한 압력이 증가하고 있으며, 이는 제약회사가 환자에게 제조 목적에 부합하는 의약품을 지속적으로 제공해야 한다는 기본적인 요구를 넘어 포장과 모방이 어려운 의약품을 생산해야 한다는 압력이 증가하고 있는 것도 시장을 촉진하는 주요 요인 중 하나입니다. 시장을 견인하는 큰 요인 중 하나입니다. 블리스터 포장은 지폐 인증 시스템과 같은 위조 방지 시스템의 효율적인 방법을 설명합니다.
• RFID(무선 주파수 식별 태그)와 같은 혁신적인 기술을 블리스터에 적용하고 포장 외부에 씰을 부착하여 공급망 전체에 걸쳐 개별적인 안전성을 제공할 수 있기 때문에 사용이 증가하고 있습니다. 블리스터 내 시료의 오염은 보호 장벽이 깨져 하나의 캡슐이나 정제가 조제 및 투약될 때만 발생합니다.
• 공급업체는 또한 환경 친화적 인 블리스터 포장 솔루션에 중점을두고 종이 기반 블리스터 포장을 도입하고 있습니다. 예를 들어, 2021년 7월 Hutamaki Oyj는 의료 산업을 위한 종이 기반 블리스터 포장 솔루션인 Push Tab을 출시했습니다. 이 제품은 FSC 인증을 받았으며 규제 대상 의약품 포장의 엄격한 안전 요건을 충족하도록 설계되었습니다.

북미의 블리스터 포장 시장 동향

의약품은 큰 폭의 성장이 예상됨

영문목차

The North America Blister Packaging Market is expected to register a CAGR of 7.5% during the forecast period.

Key Highlights

• Blister packaging is witnessing moderate growth in the North American region. The high safety offered by blister packaging solutions is augmenting the demand for these solutions. The strict regulations and demand from manufacturers and consumers alike have led to growth in the usage of blister packages. Growth in over-the-counter drugs has also provided an impetus to the market.
• Growing pressure on pharmaceutical companies to manufacture medicines that are different in packaging and hard to imitate, surpassing the basic need of keeping it useful for the purpose it was produced, for it to be made available for patients, due to growth in diseases and stringent government regulations against counterfeit drugs, are among the significant factors propelling the market. Blister packaging provides an efficient method of anti-counterfeit systems, like banknote authentication systems and others.
• The use of innovative technologies in blisters, such as RFID (radio frequency identification tags), deployed with a seal applied outside the packaging, is increasing due to the potential to offer individual security throughout supply chains. Contamination of samples in blisters only occurs when the protective barrier is broken, when a single capsule or tablet is dispensed or administered.
• Vendors are also focusing on environmentally friendly blister packaging solutions and are introducing paper-based blister packaging. For instance, in July 2021, Hutamaki Oyj launched Push Tab, a paper-based blister solution for the healthcare industry. The product is certified by FSC and is designed to meet stringent safety requirements of regulated pharmaceutical packaging.

North America Blister Packaging Market Trends

Pharmaceutical is Expected to Witness a Significant Growth

• The pharmaceutical sector poses a different set of demands for blister packaging solutions, concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine. These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
• When medicines are blister packaged, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
• The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medicines when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
• Protecting product integrity continues to be the primary goal of pharmaceutical packaging, but there is continued work on cost reduction in the packaging process in all areas of the packaging industry.
• For instance, The Polybar barrier films product families provided by Amcor cover a wide range of moisture barriers whilst also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc, among others.
• Further, the pharmaceutical companies catering to solid dose division are investing in the expansion of manufacturing facilities in North America. For instance, in September 2020, Aphena Pharma Solutions announced the expansion of the solid dose division in Cookeville, Tennessee. The comany has aimed to equip the facility with 24 high-speed bottling lines and eight thermoform blister packaging lines. This indicates the demand for blister packaging in the region.
• Moreover, according to The European Federation of Pharmaceutical Industries and Associations, North America accounted for 49% of the pharmaceutical revenue in 2020 compared to other regions across the globe. This increases demand for various blister packaging in the region.

United States to Hold the Largest Market Share

• Strict regulations, demands from manufacturers and consumers alike have led to growth in the usage of blister packages in the United States. The manufacturers are looking to earn tax incentives by manufacturing products under these regulatory standards. The promotion of Growth in over-the-counter drugs and has also provided an impetus to the market.
• Various chronic diseases raised the demand for drugs in the United States. Drug manufacturers introduced and invented effective drugs with advanced efficacies. This market also witnessed significant growth in the number of newer drug approvals given by the FDA.
• Under the blister packaging process, individual tablets or capsules are sealed within their own cavity, usually made of thermo-formed plastic or cold-form aluminum, protecting the drug from contaminants such as moisture and oxygen by a barrier of foil, film, or paperboard. Also, according to US Census Bureau, the manufacturing of pharmaceutical products could reach 365 thousand by the end of 2024. This further drives the market studied in the country.
• Furthermore, the outbreak has increased the research across the world for developing a vaccine for COVID-19. For instance, the healthcare giant, Johnson & Johnson, started clinical trials in September 2020 and has received a nearly USD 500 million partnership via a US Department of Health and Human Services division.

North America Blister Packaging Industry Overview

The North America Blister Packaging Market is moderately fragmented. Partnership, mergers, and acquisitions have been a significant strategy for the vendors in the market for producing products that are acceptable in the end-user industry, where packaging materials undergo stringent quality tests not to contaminate the contents impact health. Maintaining a continuous flow of raw materials remain a challenge that prompts partnerships. Some of the major players in the market are Amcor Ltd, Westrock Company, Sonoco Products Company, Constantia Flexibles GmbH, Honeywell International Inc., among others.

• April 2021 - Amcor announced customer trials for recyclable Polyethylene-based thermoform blister packaging. The new packaging is designed to meet the stringent requirements of highly specialized and regulated pharmaceutical packaging and creates a more sustainable alternative for the most in-demand healthcare packaging type. This innovation also benefits from up to 70% reduction in its carbon footprint when compared to packaging alternatives on the market.
• July 2021 - Huthamaki launched Push Tab paper-based blister solution for the healthcare industry. The paper used by the comany is FSC certified and acts as an alternative to traditional push-through packaging made of thermoformed PVC and aluminum, thus reducing the environmental impact across the value chain.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing geriatric population and prevalence of diseases
  • 4.2.2 Product innovations such as downsizing coupled with relatively low costs
• 4.3 Market Challenges
  • 4.3.1 Dynamic nature of regulations and inability to support heavy goods
• 4.4 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.4.1 Bargaining Power of Suppliers
  • 4.4.2 Bargaining Power of Consumers
  • 4.4.3 Threat of New Entrants
  • 4.4.4 Intensity of Competitive Rivalry
  • 4.4.5 Threat of Substitutes
• 4.5 Assessment of the Impact of COVID-19 on Blister Packaging Market

5 MARKET SEGMENTATION

• 5.1 By Process
  • 5.1.1 Thermoforming
  • 5.1.2 Coldforming
• 5.2 By Material
  • 5.2.1 Plastic Films
  • 5.2.2 Paper and Paperboard
  • 5.2.3 Aluminum
  • 5.2.4 Other Materials
• 5.3 By End-User Industry
  • 5.3.1 Consumer Goods
  • 5.3.2 Pharmaceutical
  • 5.3.3 Industrial
  • 5.3.4 Other End-User Industries
• 5.4 By Country
  • 5.4.1 United Sates
  • 5.4.2 Canada

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Amcor PLC
  • 6.1.2 Westrock Company
  • 6.1.3 Constantia Flexibles GmbH
  • 6.1.4 Sonoco Products Company
  • 6.1.5 Klockner Pentaplast Group
  • 6.1.6 E.I. Du Pont De Nemours and Company
  • 6.1.7 Honeywell International Inc.
  • 6.1.8 The Dow Chemical Company
  • 6.1.9 Tekni-Plex Inc.

7 INVESTMENT ANALYSIS

8 FUTURE OF THE MARKET